Project Grant R01NS147157
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded Icahn School of Medicine at Mount Sinai a Project Grant totaling $670,266 under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award, effective January 20, 2026 and concluding December 31, 2030, supports research to map the epigenomic and spatial transcriptomic landscape in Parkinson's Disease (PD) and Alzheimer's Disease and...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded The Johns Hopkins University a $155,000 project grant effective July 8, 2025 through June 30, 2027 under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853). The award supports the characterization of an aminoacyl-tRNA synthetase complex interacting multifunctional protein-2 (AIMP2) variant-linked mouse model of Parkinson's disease. The...
- Federal Project Grant Award Summary Stony Brook University, through The Research Foundation For The State University Of New York, received a $126,789 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award, effective June 1, 2026, through December 31, 2029, funds fundamental research investigating the role of Myocyte Enhancer Factor 2A...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $418,000 Project Grant to Harvard T.H. Chan School of Public Health, effective August 1, 2025, through July 31, 2027, under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program. The award funds a comprehensive investigation examining the potential role of viral and bacterial infections in the development of Parkinson's disease...
- Federal Grant Award Summary This Project Grant, awarded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), supports a five-year research initiative at Weill Medical College of Cornell University to investigate the role of enteric alpha-synuclein in Parkinson's disease pathophysiology. The $235,305 award (obligated July 1, 2026, through June 30, 2031) funds research...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded $131,676 to the University of Georgia Research Foundation, Inc., under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) on July 27, 2026, with a completion date of August 31, 2028. This project grant funds research investigating the role of N6-methyladenosine (m6A) reader protein YTHDF1 in microglial-mediated neuroinflammation...
- Federal Grant Award Summary The University of Georgia Research Foundation, Inc. received a $1.297 million Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award, obligated on May 8, 2026, with a completion date of April 30, 2029, supports fundamental and translational research investigating neuroinflammatory epitranscriptomic mechanisms...
- Federal Project Grant Award Summary Rockefeller University received a $220,260 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective August 1, 2025, through July 31, 2030. This five-year research initiative focuses on identifying molecular mechanisms underlying striatal dysfunction in Parkinson's disease by investigating the role of the...
- Federal Project Grant Award Summary Van Andel Research Institute (VAI) received a Project Grant award of $1,009,212 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective July 4, 2025, with completion targeted for June 30, 2027. The award supports research and development activities focused on a novel gene therapy approach to mitigate neurotoxicity in...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded San Diego Biomedical Research Institute a Project Grant of $541,750 under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, effective May 15, 2026 through April 30, 2028. This award supports the discovery of novel autophagy modulators to address Alzheimer's disease and related dementias, including frontotemporal degeneration and Lewy body...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded $627,103 to the Research Foundation For Mental Hygiene, Inc. (operating as the New York State Psychiatric Institute) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) for a five-year project period (June 1, 2026–May 31, 2031). This Project Grant supports fundamental research investigating the role of the adaptive immune system in Parkinson's disease (PD) pathogenesis, specifically examining how alpha-synuclein-specific T cells infiltrate the central nervous system (CNS) and contribute to neuronal degeneration. The research deliverables include characterization of T cell entry routes into the CNS following adoptive transfer, determination of border-associated macrophages' role in antigen re-stimulation and T cell CNS entry, and analysis of neurodegeneration mechanisms resulting from T cell–macrophage interactions using novel adoptive transfer models employing genetically-labeled Th17 and Th1 lymphocytes. This basic research effort aligns with NINDS's mission to advance fundamental knowledge of the brain and nervous system while reducing the burden of neurological disease. The project combines mechanistic investigation of neural immune interactions with translational relevance to PD pathophysiology, utilizing sophisticated experimental methodologies to elucidate immunological drivers of dopaminergic neurodegeneration. Findings from this research are expected to contribute to the scientific understanding of autoimmune mechanisms in PD and potentially inform future therapeutic interventions targeting pathological T cell infiltration in the CNS.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $627.1k | 5/29/26 |